Health Catalyst Stock
Health Catalyst, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Simeon Kohl
- Employees
- 1,200
- Market cap
- $130 M
- IPO
- 25/07/2019
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial…
Health Catalyst stock: price history
1D
-4.2%
1W
-2.5%
1M
-0.3%
6M
+30.7%
YTD
-27.8%
1Y
-44.2%
2Y
-80.2%
5Y
-96.4%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~111% stronger price swings than usual
Ask the agents about Health Catalyst
Analyst assessment of Health Catalyst
PRICE TARGET LOW
US$1.75
CONSENSUS
US$1.77
MEDIAN
US$1.75
PRICE TARGET HIGH
US$1.80
0
STRONG BUY
11
BUY
11
HOLD
0
SELL
0
STRONG SELL
22
TOTAL · Buy
As of: 21/08/2026
Health Catalyst stock metrics
P/E
-0.47
P/B
1.27
EV/EBITDA
-1.2
RETURN ON EQUITY
-40.2%
NET MARGIN
-57.5%
DEBT/EQUITY
1.69
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
78.8%
FLOAT SHARES
59,269,668
AVG. DAILY VOLUME (30D)
466,120
Insider transactions (SEC)
Reller Tami
Kohl Simeon
Kohl Simeon
Albert Benjamin
Larson-Green Julie
Institutional holders
Comparable stocks
Frequently asked questions about Health Catalyst stock
What does Health Catalyst do?
Health Catalyst, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Simeon Kohl, the company employs around 1,200 people.
The IPO was on 25/07/2019; the stock trades on NASDAQ under the ticker HCAT.
What do analysts say about Health Catalyst stock?
22 analysts rate the stock, the consensus is Buy (as of 21/08/2026).
The average price target is US$1.77, ranging from US$1.75 to US$1.80, with a median of US$1.75.
This is an external assessment, not a statement by Market Jury.
When does Health Catalyst report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 111% stronger than usual.
Does Health Catalyst pay a dividend?
No, Health Catalyst currently does not pay a dividend.
Which stocks are comparable to Health Catalyst?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Health Catalyst stock analyzed?
Clicking "Analyze stock" lets five strategies assess Health Catalyst against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.